Use of tocilizumab in amyloid a nephropathy associated with Sweet syndrome: a case report and literature review-Reference-Cited by-同舟云学术

Use of tocilizumab in amyloid a nephropathy associated with Sweet syndrome: a case report and literature review

Published:2020-07-17 Issue:1 Volume:10 Page:23-29
ISSN:2192-4449
Container-title:CEN Case Reports
language:en
Short-container-title:CEN Case Rep

Author:

Giannese D.^ORCID,Ferro F.,Moriconi D.,Bonadio A. G.,Elefante E.,Egidi M. F.,Cupisti A.,Baldini C.

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://link.springer.com/content/pdf/10.1007/s13730-020-00507-4.pdf

Reference30 articles.

1. Lackmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Eng J Med. 2007;356(23):2361–71.

2. Sack GH Jr. Serum amyloid—a review. Mol Med. 2018;24:46.

3. Scapioni R, et al. Renal involvement in autoinflammatory diseases and inflammasome-mediated chronic kidney damage. Clin and Exp Rheum. 2018;110(1):54–60.

4. Benditt EP, et al. Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci USA. 1977;74:4025–8.

5. Del Campo JA, et al. Role of inflammatory response in liver diseases: therapeutic strategies. World J Hepatol. 2018;10(1):1–7.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Giant Cellulitis-Like Sweet Syndrome Masquerading As Cellulitis and Shingles: A Case Report and Literature Review;Cureus;2023-03-16

2. Serum Amyloid A Protein–Associated Kidney Disease: Presentation, Diagnosis, and Management;Kidney Medicine;2022-08

3. New Practical Aspects of Sweet Syndrome;American Journal of Clinical Dermatology;2022-02-14

4. Cyclophosphamide/leflunomide/prednisone;Reactions Weekly;2021-03